Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |
| Evoke Pharma Inc. | 0 | 23 | 0 | 1 | €0.40 | - | - |
| InVivo Therapeutics Holdings | 1 | 17 | 0 | 0 | €0.32 | €1.60 | 403.145% |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
| Trevena Inc. | 1 | 14 | 0 | 2 | €0.37 | €8.37 | 2161.189% |
| T2 Biosystems Inc. | 0 | 11 | 0 | 0 | €0.16 | - | - |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 1 | 0 | €0.22 | €14.66 | 6565.591% |
| BioLase Inc. | 0 | 7 | 0 | 1 | €0.067 | - | - |
| Organovo Holdings Inc. | 0 | 6 | 0 | 1 | €0.91 | - | - |
| CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.42 | - | - |
| Avinger Inc. | 2 | 7 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €2.10 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.38 | €7.00 | 194.118% |
| Fibrogen Inc. | 1 | 4 | 0 | 0 | €1.16 | €0.000 | -100.000% |
| ViewRay Inc | 0 | 3 | 0 | 0 | €0.025 | - | - |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €7.25 | €7.00 | -3.448% |
| Cardiff Oncology Inc. | 2 | 4 | 1 | 1 | €3.20 | €5.00 | 56.250% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €1.01 | €6.49 | 540.543% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 1 | €0.49 | €2.79 | 474.877% |
| Integra LifeSciences Holdings Corp | 3 | 5 | 0 | 2 | €23.00 | €34.68 | 50.776% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.55 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.41 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.44 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.52 | €3.00 | 476.037% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.38 | - | - |